Received Mar 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (HEPLISAV-B) | DYNAVAX TECHNOLOGIES CORPORATION | 1 | 945660 | IM / LA |
patient started to experience fever-like symptoms, severe headache and weakness.
none; no symptoms
none
none
none per patient report
none